142 related articles for article (PubMed ID: 27671369)
1. Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases.
Nelson AS; Vajdic CM; Ashton LJ; Le Marsney RE; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
Pediatr Blood Cancer; 2017 Jan; 64(1):197-202. PubMed ID: 27671369
[TBL] [Abstract][Full Text] [Related]
2. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
Thakar MS; Broglie L; Logan B; Artz A; Bunin N; Burroughs LM; Fretham C; Jacobsohn DA; Loren AW; Kurtzberg J; Martinez CA; Mineishi S; Nelson AS; Woolfrey A; Pasquini MC; Sorror ML
Blood; 2019 Feb; 133(7):754-762. PubMed ID: 30545834
[TBL] [Abstract][Full Text] [Related]
3. Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
Li Q; Luo C; Luo C; Wang J; Li B; Ding L; Chen J
Ann Hematol; 2017 Aug; 96(8):1389-1397. PubMed ID: 28623394
[TBL] [Abstract][Full Text] [Related]
4. Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy.
Nelson AS; Ashton LJ; Vajdic CM; Le Marsney RE; Daniels B; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA;
Leukemia; 2015 Feb; 29(2):441-7. PubMed ID: 24962016
[TBL] [Abstract][Full Text] [Related]
5. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2018 Jan; 103(1):30-39. PubMed ID: 29051281
[TBL] [Abstract][Full Text] [Related]
6. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
[TBL] [Abstract][Full Text] [Related]
7. [Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary].
Kállay K; Csomor J; Ádám E; Bödör C; Kassa C; Simon R; Kovács G; Péter G; Ottóffy G; Bartyik K; Kiss C; Masát P; Réti M; Tóth B; Kriván G
Orv Hetil; 2018 Oct; 159(42):1710-1719. PubMed ID: 30334483
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood.
Holmqvist AS; Chen Y; Wu J; Battles K; Bhatia R; Francisco L; Hageman L; Kung M; Ness E; Parman M; Salzman D; Wadhwa A; Winther JF; Rosenthal J; Forman SJ; Weisdorf DJ; Armenian SH; Arora M; Bhatia S
JAMA Oncol; 2018 Dec; 4(12):e182453. PubMed ID: 30054602
[TBL] [Abstract][Full Text] [Related]
9. Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease.
Choi YB; Lee JW; Sung KW; Koo HH; Kim HJ; Yoo KH
J Korean Med Sci; 2019 Feb; 34(6):e46. PubMed ID: 30787679
[TBL] [Abstract][Full Text] [Related]
10. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia.
Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Lee JW
Eur J Haematol; 2017 Oct; 99(4):336-343. PubMed ID: 28675769
[TBL] [Abstract][Full Text] [Related]
12. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: one center's experience.
Shaw PH; Haut PR; Olszewski M; Kletzel M
Pediatr Transplant; 1999 Nov; 3(4):315-21. PubMed ID: 10562977
[TBL] [Abstract][Full Text] [Related]
14. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
Peffault de Latour R; Peters C; Gibson B; Strahm B; Lankester A; de Heredia CD; Longoni D; Fioredda F; Locatelli F; Yaniv I; Wachowiak J; Donadieu J; Lawitschka A; Bierings M; Wlodarski M; Corbacioglu S; Bonanomi S; Samarasinghe S; Leblanc T; Dufour C; Dalle JH; ;
Bone Marrow Transplant; 2015 Sep; 50(9):1168-72. PubMed ID: 26052913
[TBL] [Abstract][Full Text] [Related]
15. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy.
Khalil A; Zaidman I; Elhasid R; Peretz-Nahum M; Futerman B; Ben-Arush M
Pediatr Hematol Oncol; 2012 Nov; 29(8):694-703. PubMed ID: 23020512
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families.
Bona K; London WB; Guo D; Abel G; Lehmann L; Wolfe J
Biol Blood Marrow Transplant; 2015 Feb; 21(2):312-8. PubMed ID: 25445021
[TBL] [Abstract][Full Text] [Related]
18. Long-term systolic function in children and young adults after hematopoietic stem cell transplant.
Rotz SJ; Dandoy CE; Taylor MD; Jodele S; Jefferies JL; Lane A; El-Bietar JA; Powell AW; Davies SM; Ryan TD
Bone Marrow Transplant; 2017 Oct; 52(10):1443-1447. PubMed ID: 28714947
[TBL] [Abstract][Full Text] [Related]
19. Risk factor analysis of bloodstream infection in pediatric patients after hematopoietic stem cell transplantation.
Sarashina T; Yoshida M; Iguchi A; Okubo H; Toriumi N; Suzuki D; Sano H; Kobayashi R
J Pediatr Hematol Oncol; 2013 Jan; 35(1):76-80. PubMed ID: 22995926
[TBL] [Abstract][Full Text] [Related]
20. Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan.
Asano T; Kogawa K; Morimoto A; Ishida Y; Suzuki N; Ohga S; Kudo K; Ohta S; Wakiguchi H; Tabuchi K; Kato S; Ishii E
Pediatr Blood Cancer; 2012 Jul; 59(1):110-4. PubMed ID: 22038983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
